The new Medicare GLP-1 Bridge program offers broader, more affordable access to weight loss drugs to address the growing ...

Medicare is launching a temporary program that will cover Novo’s Wegovy injection and tablets, as well as Lilly’s Zepbound ...

For the first time, Medicare will cover GLP-1 drugs prescribed solely for weight loss for eligible beneficiaries at a $50 ...

A new pilot program for adults with Medicare Part D coverage will cut the price of Wegovy, Zepbound, and Foundayo. Find out ...

Starting this week, the federal government is offering a selection of the brand name medications to certain Medicare and Medicare Advantage beneficiaries for $50 a month through a new trial called ...

GoodRx reports that Medicare's new GLP-1 Bridge program allows eligible Part D enrollees to access weight-loss medications ...

CMS says the 18-month demonstration will expand access to select weight-loss drugs while the agency gathers data on uptake, outcomes and program operations.

Millions of people could meet criteria to receive GLP-1s, which could cost Medicare billions of dollars, according to a ...

Medicare will start the GLP-1 Bridge program July 1. Older adults who qualify for the weight-loss drugs will pay a monthly ...

Does Medicare pay for GLP-1 drugs like Ozempic for weight loss? For years, the answer has been a hard no. But a new “Bridge” ...

Medicare is rolling out a new program that will provide low-cost access to GLP-1s for weight loss.

Pharmacists can help answer questions about eligibility requirements, participating medications, prior authorization ...